Observational studyClinical cardiology2015

Characterizing major bleeding in patients with nonvalvular atrial fibrillation: a pharmacovigilance study of 27 467 patients taking rivaroxaban.

Sally Tamayo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.